Report Categories
View AllRecent Articles
View All
KNF Knife Riv Q4 2025 EPS beats consensus estimates by 332 percent as shares climb 19 percent amid upbeat investor reaction
State Street Health Care Select Sector SPDR ETF XLV Constituent Gilead Sciences GILD Posts Strong Pipeline Momentum Secures Street Consensus Strong Buy Rating
ZTEK Zentek posts narrow Q3 2023 EPS beat shares drop 216 in todays trading
What Traws Pharma TRAW customer metrics tell us about future growth Traws Pharma earns 063 EPS beats loss estimates